Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
BMC Gastroenterol ; 23(1): 94, 2023 Mar 28.
Article in English | MEDLINE | ID: mdl-36977983

ABSTRACT

BACKGROUND: Evidence indicates that inflammation in Inflammatory Bowel Disease (IBD) is associated with increased systemic levels of reactive oxygen species. Systemic oxidative stress has been associated with reduced levels of plasma thiols. Less invasive tests capable of reflecting and predicting IBD activity are increasingly sought after. We sought to systematically review the evidence inherent in serum thiol levels as a marker of Crohn's Disease and Ulcerative Colitis activity (PROSPERO: CRD42021255521). METHODS: The highest quality documents for systematic reviews standards were used as reference. Articles were searched on Medline via PubMed, VHL, LILACS, WOS, EMBASE, SCOPUS, COCHRANE, CINAHL, OVID, CTGOV, WHO/ICTRP, OPENGREY, BDTD and CAPES, between August, 03 and September, 03 on 2021. Descriptors were defined according to the Medical Subject Heading. Of the 11 articles selected for full reading, 8 were included in the review. It was not possible to perform a pooled analysis of the studies, as there were no combinable studies between subjects with active IBD and controls/inactive disease. RESULTS: Findings from the individual studies included in this review suggest an association between disease activity and systemic oxidation, as measured by serum thiol levels, however, there are limitations that preclude weighting the study results in a meta-analysis. CONCLUSIONS: We recommend conducting better-designed and controlled studies, that include individuals of both phenotypes and at different stages of IBD, involving a larger number of participants, using the standardization of the technique for measuring serum thiols, to confirm whether thiols can be a good parameter for monitoring the clinical course of these intestinal diseases and the degree of clinical applicability.


Subject(s)
Colitis, Ulcerative , Crohn Disease , Inflammatory Bowel Diseases , Humans , Colitis, Ulcerative/complications , Crohn Disease/complications , Inflammatory Bowel Diseases/diagnosis , Inflammatory Bowel Diseases/complications , Sulfhydryl Compounds
2.
Nutrients ; 12(8)2020 Jul 31.
Article in English | MEDLINE | ID: mdl-32751776

ABSTRACT

The objective of this study was to systematically review the literature to verify the efficacy and safety of curcumin as a complementary therapy for the maintenance or induction of remission in patients with inflammatory bowel disease (IBD). A comprehensive search was conducted by two independent authors in MEDLINE (PubMed), Scopus, Web of Science, the Cochrane Library, Lilacs, Food Science and Technology Abstracts, and ScienceDirect. The search terms "curcumin", "curcuma", "inflammatory bowel disease", "proctocolitis", "crohn disease", and "inflammation" were combined to create search protocols. This study considered randomized controlled trials (RCTs) published in any language before March 2020 that evaluated the effects of curcumin on inflammatory activity and the maintenance or remission of IBD patients. After duplicates were removed, 989 trials were identified, but only 11 met the eligibility criteria. Five of these were considered to be biased and were excluded. Therefore, six trials were considered in this review. All the studies included in the systematic review were placebo-controlled RCTs conducted on individuals with ulcerative colitis (UC). All the RCTs reported that curcumin was well tolerated and was not associated with any serious side effects. Studies show that curcumin may be a safe, effective therapy for maintaining remission in UC when administered with standard treatments. However, the same cannot be stated for Crohn's disease due to the lack of low bias risk studies. Further studies with larger sample sizes are needed before curcumin can be recommended as a complementary therapy for UC.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Colitis, Ulcerative/drug therapy , Complementary Therapies/methods , Curcumin/therapeutic use , Adult , Crohn Disease/drug therapy , Female , Humans , Inflammatory Bowel Diseases/drug therapy , Male , Middle Aged , Randomized Controlled Trials as Topic , Treatment Outcome , Young Adult
3.
Food Funct ; 11(7): 6588-6594, 2020 Jul 01.
Article in English | MEDLINE | ID: mdl-32648861

ABSTRACT

Coconut oil appears to help in weight loss and improve metabolic parameters associated with obesity. We evaluate the influence of coconut oil on the body composition, lipid profile and glycemia in men with obesity. A controlled, randomized clinical trial was performed with 29 adult men affected by obesity. They were randomized between two groups receiving a daily intake of 1 tablespoon (12 mL) of extra virgin coconut oil (CO, n = 15) or soybean oil (SO, n = 14), and an isoenergetic balanced diet. The anthropometric profile, lipid profile and glycaemia were evaluated at the baseline and 45 days after intervention. The Mann-Whitney test was performed to compare the groups, and the Wilcoxon test was performed to compare the times. We considered a value of p < 0.05 as significant. There was no difference in anthropometric variables between the groups before and after intervention. The level of HDL cholesterol increased (3.67 ± 8.08 versus-3.79 ± 10.98, p = 0.02) and the TC/HDL cholesterol ratio decreased (-0.63 ± 0.82 versus 0.23 ± 0.80, p = 0.03) in the CO group, compared to the SO group. Coconut oil included in the isoenergetic balanced diet could increase HDL cholesterol and decrease the TC/HDL cholesterol ratio in men with obesity.


Subject(s)
Blood Glucose/analysis , Coconut Oil/administration & dosage , Lipids/blood , Obesity/drug therapy , Weight Loss/drug effects , Adult , Cholesterol , Cholesterol, HDL/blood , Diet , Energy Intake , Humans , Male , Middle Aged , Obesity/blood , Waist-Hip Ratio
4.
Arch Endocrinol Metab ; 62(3): 285-295, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29791653

ABSTRACT

OBJECTIVE: The role of bone markers on insulin resistance (IR) remains controversial. The objective of this study is to evaluate the association between bone mineral density (BMD) and glucose metabolism and investigate if visceral hyperadiposity, evaluated by waist circumference (WC), is an effect modifier of this association. SUBJECTS AND METHODS: Cross-sectional analysis with 468 young adults from the fourth follow-up of the 1978/79 Ribeirão Preto prospective birth cohort, Brazil. BMD, total osteocalcin (OC), fasting plasma glucose and insulin concentrations were assessed. IR, sensitivity (S) and secretion (ß) were estimated by homeostasis model assessment (HOMA) indexes. Multiple linear regression models were constructed to estimate the association between BMD and glucose metabolism. Beta coefficient, R2 and p-values were provided. WC was tested as an effect modifier and OC as a confounder. The covariates were selected based on Direct Acyclic Graph. RESULTS: Significant interaction between BMD (femoral neck and proximal femur areas) and WC on glucose metabolism was observed in the adjusted models. Subjects with increased WC presented a positive association between BMD and log HOMA1-IR while an inverse association was found in those with normal WC (femoral neck R2 = 0.17, p = 0.036; proximal femur R2 = 0.16, p = 0.086). BMD was negatively associated with log HOMA2-S in individuals with increased WC and positively in those with normal WC (femoral neck R2 = 0.16, p = 0.042; proximal femur R2 = 0.15, p = 0.097). No significant associations between BMD, log HOMA2-ß and OC and glucose metabolism markers were observed. CONCLUSIONS: BMD was associated with glucose metabolism, independently of OC, and WC modifies this association.


Subject(s)
Blood Glucose/metabolism , Bone Density/physiology , Immunologic Factors/physiology , Intra-Abdominal Fat/physiology , Waist Circumference/physiology , Adult , Blood Glucose/physiology , Cross-Sectional Studies , Fasting , Female , Humans , Insulin/blood , Male , Osteocalcin/blood
5.
Arch. endocrinol. metab. (Online) ; 62(3): 285-295, May-June 2018. tab, graf
Article in English | LILACS | ID: biblio-950068

ABSTRACT

ABSTRACT Objective: The role of bone markers on insulin resistance (IR) remains controversial. The objective of this study is to evaluate the association between bone mineral density (BMD) and glucose metabolism and investigate if visceral hyperadiposity, evaluated by waist circumference (WC), is an effect modifier of this association. Subjects and methods: Cross-sectional analysis with 468 young adults from the fourth follow-up of the 1978/79 Ribeirão Preto prospective birth cohort, Brazil. BMD, total osteocalcin (OC), fasting plasma glucose and insulin concentrations were assessed. IR, sensitivity (S) and secretion (β) were estimated by homeostasis model assessment (HOMA) indexes. Multiple linear regression models were constructed to estimate the association between BMD and glucose metabolism. Beta coefficient, R2 and p-values were provided. WC was tested as an effect modifier and OC as a confounder. The covariates were selected based on Direct Acyclic Graph. Results: Significant interaction between BMD (femoral neck and proximal femur areas) and WC on glucose metabolism was observed in the adjusted models. Subjects with increased WC presented a positive association between BMD and log HOMA1-IR while an inverse association was found in those with normal WC (femoral neck R2 = 0.17, p = 0.036; proximal femur R2 = 0.16, p = 0.086). BMD was negatively associated with log HOMA2-S in individuals with increased WC and positively in those with normal WC (femoral neck R2 = 0.16, p = 0.042; proximal femur R2 = 0.15, p = 0.097). No significant associations between BMD, log HOMA2-β and OC and glucose metabolism markers were observed. Conclusions: BMD was associated with glucose metabolism, independently of OC, and WC modifies this association.


Subject(s)
Humans , Male , Female , Adult , Blood Glucose/metabolism , Bone Density/physiology , Intra-Abdominal Fat/physiology , Waist Circumference/physiology , Immunologic Factors/physiology , Blood Glucose/physiology , Osteocalcin/blood , Cross-Sectional Studies , Fasting , Insulin/blood
6.
Article in English | MEDLINE | ID: mdl-25865679

ABSTRACT

Neonatal hypoxic-ischemic (HI) encephalopathy is a major cause of perinatal morbimortality. There is growing evidence that n-3 polyunsaturated fatty acids, especially docosahexaenoic acid (DHA), attenuate brain injury. This study aimed to investigate the possible neuroprotective effect of maternal intake of flaxseed, rich in DHA׳s precursor α-linolenic acid, in the young male offspring subjected to perinatal HI. Wistar rats were divided in six groups, according to maternal diet and offspring treatment at day 7: Control HI (CHI) and Flaxseed HI (FHI); Control Sham and Flaxseed Sham; Control Control and Flaxseed Control. Flaxseed diet increased offspring׳s hippocampal DHA content and lowered depressive behavior. CHI pups presented brain mass loss, motor hyperactivity and poor spatial memory, which were improved in FHI rats. Maternal flaxseed intake may prevent depressive symptoms in the offspring and promote neuroprotective effects, in the context of perinatal HI, improving brain injury and its cognitive and behavioral impairments.


Subject(s)
Brain/drug effects , Flax/chemistry , Hyperkinesis/prevention & control , Hypoxia-Ischemia, Brain/prevention & control , Plant Extracts/pharmacology , Spatial Memory/drug effects , Analysis of Variance , Animals , Animals, Newborn , Brain/metabolism , Brain/pathology , Brain Injuries/physiopathology , Brain Injuries/prevention & control , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/pharmacology , Female , Hyperkinesis/physiopathology , Hypoxia-Ischemia, Brain/physiopathology , Male , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/pharmacology , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Pregnancy , Rats , Rats, Wistar , Seeds/chemistry , Time Factors , alpha-Linolenic Acid/administration & dosage , alpha-Linolenic Acid/pharmacology
7.
World J Gastroenterol ; 21(5): 1614-20, 2015 Feb 07.
Article in English | MEDLINE | ID: mdl-25663781

ABSTRACT

AIM: To assess the vitamin A status of patients with Crohn's disease (CD) by evaluating serum retinol levels and the relative dose response (RDR) test (liver retinol stores). METHODS: Vitamin A nutritional status was measured by serum retinol obtained by high performance liquid chromatography and the RDR test for evaluation of the hepatic stores. Body composition was performed by densitometry by dual-energy X-ray absorptiometry. Vitamin A dietary intake was assessed from a semi-quantitative food frequency questionnaire. RESULTS: This study included 38 CD patients and 33 controls. Low serum retinol concentrations were detected in 29% of CD patients vs 15% in controls (P < 0.005). The RDR test was positive in 37% of CD patients vs 12% in controls, which indicated inadequate hepatic vitamin A stores (P < 0.005). Individuals with hypovitaminosis A had lower BMI and body fat compared with those without this deficiency. There was no association between vitamin A deficiency and its dietary intake, ileal location, presence of disease activity and prior bowel resections. CONCLUSION: Patients with CD have higher prevalence of vitamin A deficiency, as assessed by two independent methods.


Subject(s)
Crohn Disease/epidemiology , Liver/chemistry , Vitamin A Deficiency/diagnosis , Vitamin A Deficiency/epidemiology , Vitamin A/blood , Absorptiometry, Photon , Adiposity , Adult , Biomarkers/blood , Body Mass Index , Brazil/epidemiology , Case-Control Studies , Chromatography, High Pressure Liquid , Crohn Disease/diagnosis , Crohn Disease/physiopathology , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Nutrition Assessment , Nutritional Status , Predictive Value of Tests , Prevalence , Surveys and Questionnaires , Vitamin A Deficiency/blood , Vitamin A Deficiency/physiopathology
8.
Brain Res ; 1496: 10-27, 2013 Feb 16.
Article in English | MEDLINE | ID: mdl-23123702

ABSTRACT

There is no consensus about the effects of protein restriction on neurogenesis and behavior. Here, for the first time, we evaluated the effects of protein restriction during gestation and lactation, on the two major neurogenic regions of the adult brain, the subgranular zone (SGZ) of the hippocampal dentate gyrus and the subventricular zone (SVZ), simultaneously. We also assessed different types of behavior relevant to each region. After mating, pregnant Wistar rats were divided into a control group (CG) that received a normal diet (20% protein); and a protein-restriction group (PRG) that received a low-protein diet (8% protein). After birth, the same diets were provided to the mother and pups until weaning, when some rats were analyzed and others received a normal-protein diet until adulthood. Different sets of rats were used for cellular and behavioral studies in juvenile or adult age. Brains were processed for immunohistochemistry anti-BrdU, anti-Ki67, or anti-pHisH3. Juvenile and adult rats from distinct litters also underwent several behavioral tests. Our data show that early protein restriction results in a reduction of hippocampal progenitors and deficits in object recognition during adult life. Moreover, longer periods of immobility in the tail suspension and in the forced swimming tests revealed that PRG rats show a depressive behavior at 21 days of age (P21) and in adulthood. Furthermore, we suggest that despite the reduced number/proliferation of neural stem cells (B and/or E cells) in SVZ there is a compensatory mechanism in which the progenitors (types C and A cells) proliferate in a higher rate, without affecting olfactory ability in adulthood.


Subject(s)
Cell Proliferation/drug effects , Cerebral Ventricles/pathology , Diet, Protein-Restricted/adverse effects , Hippocampus/pathology , Lactation/drug effects , Prenatal Exposure Delayed Effects/pathology , Age Factors , Animals , Animals, Newborn , Avoidance Learning/drug effects , Avoidance Learning/physiology , Bromodeoxyuridine/metabolism , Exploratory Behavior/drug effects , Female , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Hindlimb Suspension/methods , Histones/metabolism , Ki-67 Antigen/metabolism , Lactation/physiology , Male , Maze Learning/drug effects , Neurogenesis/drug effects , Neurogenesis/physiology , Pregnancy , Rats , Rats, Wistar , Swimming
9.
J Neurosci Res ; 71(3): 455-61, 2003 Feb 01.
Article in English | MEDLINE | ID: mdl-12526033

ABSTRACT

The superficial layers of the rat superior colliculus (sSC) receive innervation from the retina and include nitrergic neurons. We have shown previously that in sSC, eye enucleation reduces NADPH diaphorase staining considerably in all but the most proximal dendrites of nitrergic neurons. We have used immunocytochemistry for neuronal nitric oxide synthase (nNOS) at light and electron microscopic levels and bilateral eye enucleation with varied survival times to determine the regulatory changes imposed by the direct and indirect loss of retinal input on apparent nNOS amount and subcellular distribution. In addition, we have used SDS-PAGE and immunoblotting to test alternatively spliced isoforms in normal and deafferented animals. Our results show that unambiguously identified retinal terminals contact nitrergic neurons. In normal dendrites, nNOS immunoreactivity was distributed almost completely within the cytoplasm of the dendrite and along the postsynaptic membrane at synaptic junctions, in association with endoplasmic reticulum, ribosomes and external mitochondrial membranes. In contrast, nNOS labeling was greatly reduced in sSC deprived of retinal projections, and could only be observed in association with mitochondrial membranes and postsynaptic densities. Immunoblots of the soluble fraction from sSC revealed a surprisingly high proportion of the beta isoform with respect to the alpha counterpart in normal colliculi, suggesting an increase in isoform proportion after enucleation, or at least maintenance of the same proportion. It is suggested that ultrastructural alterations observed in sSC cells of enucleated animals may be consequent to plastic reactions of the sSC cells in response to the removal of retinal afferents.


Subject(s)
Dendrites/enzymology , Nitrergic Neurons/enzymology , Nitric Oxide Synthase/analysis , Retina/enzymology , Superior Colliculi/enzymology , Afferent Pathways/enzymology , Afferent Pathways/ultrastructure , Animals , Dendrites/ultrastructure , Isoenzymes/analysis , Isoenzymes/biosynthesis , Nitrergic Neurons/ultrastructure , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type I , Rats , Retina/ultrastructure , Superior Colliculi/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...